“JBC did primary market research with about 30 international organisations for Sphere Fluidics on our new single cell analysis technology platform (Cyto-Mine®). The report was impressive and the findings were critical in shaping the product specifications, pricing sales and routes to market. The quality and objectivity of their report also helped build confidence with Sphere Fluidics investors and was seminal in us winning a $multi-million investment round. I recommend JBC highly for their business acumen, knowledge of the Life Sciences Tools industry and professional analysis skills”.
- Frank Craig, CEO Sphere Fluidics
- Product market fit testing viability of proposed products resulting in precision launch of product and VC funding of Series B
- Lead generation resulting in 20 new projects
- Channel development in Asia resulting in over 200K sales within 4 months of launch.
-KOL development resulting in successful marketing launch and publications.
- Rob Donoho, VP Sales and Marketing Sword Diagnostics.